Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin

Trends in Incidence of Type 1 and Type 2 Diabetes Among Youths — Selected Counties and Indian Reservations, United States, 2002–2015

(2020) Jasmin Divers et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Progress in understanding youth-onset type 2 diabetes in the United States: recent lessons from clinical trials

(2019) Philip Zeitler   World Journal of Pediatrics

Rapid progression of type 2 diabetes and related complications in children and young people—A literature review

(2019) Timothy Barrett et al.   PEDIATRIC DIABETES

Type 2 Diabetes in Youth: New Lessons from the SEARCH Study

(2018) Elizabeth T. Jensen et al.   Current Diabetes Reports

Type 2 diabetes in adolescents and young adults

(2018) Nadia Lascar et al.   Lancet Diabetes & Endocrinology

Eligibility for clinical trials is limited for youth with type 2 diabetes (T2D): Insights from the Pediatric Diabetes Consortium T2D Clinic Registry

(2018) William V. Tamborlane et al.   PEDIATRIC DIABETES

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2018) Melanie J. Davies et al.   DIABETES CARE

A randomized clinical trial to evaluate the single-dose pharmacokinetics, pharmacodynamics, and safety of sitagliptin in pediatric patients with type 2 diabetes

(2018) Iain P. Fraser et al.   PEDIATRIC DIABETES

Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden

(2017) Russell Viner et al.   LANCET

Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium

(2015) Georgeanna J. Klingensmith et al.   PEDIATRIC DIABETES

Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Pediatric Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

(2014) David J. Klein et al.   Diabetes Technology & Therapeutics

Sitagliptin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus

(2014) Greg L. Plosker   DRUGS

Prevalence of Diabetes in U.S. Youth in 2009: The SEARCH for Diabetes in Youth Study

(2013) D. J. Pettitt et al.   DIABETES CARE

Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and  -Cell Function in TODAY

(2013)   DIABETES CARE

Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies

(2013) Samuel S. Engel et al.   Diabetes Therapy

A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

DPP-4 inhibitors in the treatment of type 2 diabetes

(2011) Hélène Duez et al.   BIOCHEMICAL PHARMACOLOGY

Effects of Rosiglitazone, Glyburide, and Metformin on  -Cell Function and Insulin Sensitivity in ADOPT

(2011) S. E. Kahn et al.   DIABETES

Effect of initial combination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes

(2011) D. Williams-Herman et al.   DIABETES OBESITY & METABOLISM

Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes

(2010) D. Williams-Herman et al.   DIABETES OBESITY & METABOLISM

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

(2010) T. Seck et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study

(2009) Debora Williams-Herman et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

(2009) T. Vilsbøll et al.   DIABETES OBESITY & METABOLISM

Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study

(2009)   INTERNATIONAL JOURNAL OF OBESITY

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

(2008) Itamar Raz et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes*

(2008) R. Scott et al.   DIABETES OBESITY & METABOLISM